Stockreport

Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer [Yahoo! Finance]

Kintara Therapeutics, Inc.  (KTRA) 
PDF SAN DIEGO Feb. 12, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development o [Read more]